Workflow
Healthcare services
icon
Search documents
Community Health Systems to Webcast Third Quarter 2025 Conference Call
Businesswire· 2025-10-09 15:00
You can join the live call by dialing 1-833-630-1961 (domestic) or 1-412-317-1842 (international). Once connected, request to be joined into the Community Health Systems, Inc. call. A telephonic replay of the conference call will be available through October 30, 2025, by dialing 1-877-344-7529 and entering the confirmation number, 9596131. About Community Health Systems, Inc. Community Health Systems, Inc. is one of the nation's largest healthcare companies. The Company's affiliates are leading providers of ...
CVS Health’s (CVS) Payout Strength Compared to Other October Dividend Stocks
Yahoo Finance· 2025-09-30 18:21
Core Insights - CVS Health Corporation is recognized as one of the Best High Yield Stocks to Buy in October [1] - The company operates beyond a pharmacy chain, providing healthcare services such as lab work, health screenings, vaccinations, and treatment for minor injuries through in-store clinics [2] - CVS Health owns Aetna, the fifth largest health insurer in the U.S., covering 36 million people [3] Business Operations - CVS commands approximately 27% of the nationwide prescription volume in the pharmacy sector [4] - The company has been focusing on a value-based healthcare model, enhancing its primary care and home-based care capabilities through acquisitions like Signify Health and Oak Street Health [4] - CVS has consistently paid dividends to shareholders since 1997, currently offering a quarterly dividend of $0.665 per share, resulting in a 3.51% dividend yield as of September 27 [5]
UBS Raises PT on UnitedHealth Group Incorporated (UNH)  to $378, Maintains ‘Buy’ Rating
Yahoo Finance· 2025-09-22 22:40
Group 1 - UnitedHealth Group Incorporated (NYSE:UNH) is recognized as one of the Top 15 Stocks to Buy across 11 different sectors for the next 3 months [1] - UBS has raised its price target for UnitedHealth Group from $330 to $378 while maintaining a 'Buy' rating, following the reaffirmation of 2025 guidance and steady Stars ratings through 2027 [2] - The company operates globally through its UnitedHealthcare insurance arm and Optum's analytics, pharmacy, and care delivery businesses, making it one of the Best Diversified Stocks [3] Group 2 - Despite the potential of UnitedHealth as an investment, certain AI stocks are considered to offer greater upside potential with less downside risk [4]
UnitedHealth Group (UNH): A Healthcare Powerhouse Among Dividend Paying Stocks
Yahoo Finance· 2025-09-21 03:36
Group 1 - UnitedHealth Group Incorporated (NYSE:UNH) is recognized as one of the 12 best dividend-paying stocks to buy now, highlighting its strong position in the market [1] - The company operates primarily through its UnitedHealthcare division for insurance products and its Optum unit for healthcare services, establishing itself as a major player in the healthcare industry [2] - Despite facing significant challenges, including a major data breach linked to its subsidiary Change Healthcare and leadership changes, the company's appeal remains strong due to its consistent dividend payments [3][4] Group 2 - UnitedHealth Group has increased its dividends for 14 consecutive years, currently paying a quarterly dividend of $2.21 per share, resulting in a dividend yield of 2.63% as of September 19 [4]
Elevance Health, Inc. (ELV) Reaffirms Full-Year 2025 Earnings Guidance
Yahoo Finance· 2025-09-12 15:09
Core Insights - Elevance Health, Inc. (NYSE:ELV) is reaffirming its full-year 2025 earnings guidance, expecting earnings of approximately $24.10 per diluted share, which includes about $5.90 per share in net unfavorable items, leading to adjusted earnings of roughly $30.00 per diluted share when excluding these items [2][3] Group 1 - The company anticipates a benefit expense ratio close to 90% for the year, based on current market conditions, regulatory factors, and medical cost trends [3] - Elevance Health operates under several brands, including Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon, providing health benefits, pharmacy, and healthcare services across the U.S. [3] - Elevance Health is recognized as one of the best Roth IRA stocks to invest in currently [1][3]
Phreesia (PHR) Reports Q2 Earnings: What Key Metrics Have to Say
ZACKS· 2025-09-04 23:00
Core Insights - Phreesia reported revenue of $117.26 million for the quarter ended July 2025, reflecting a year-over-year increase of 14.8% and a surprise of +0.7% over the Zacks Consensus Estimate of $116.45 million [1] - The company's EPS was $0.01, a significant improvement from -$0.31 in the same quarter last year, resulting in an EPS surprise of +114.29% compared to the consensus estimate of -$0.07 [1] Financial Performance Metrics - Average healthcare services clients were reported at 4,467, slightly below the three-analyst average estimate of 4,475 [4] - Patient payment volume reached $1.25 billion, exceeding the average estimate of $1.18 billion from three analysts [4] - Payment facilitator volume percentage was 82%, closely aligning with the average estimate of 82.2% based on two analysts [4] - Revenue from subscription and related services was $53.7 million, below the average estimate of $55.27 million from six analysts, but still showing a year-over-year increase of +10.5% [4] - Revenue from network solutions was $35.16 million, surpassing the six-analyst average estimate of $33.25 million, with a year-over-year change of +24.7% [4] - Revenue from payment processing fees was $28.39 million, slightly above the six-analyst average estimate of $27.9 million, reflecting a year-over-year increase of +12.2% [4] Stock Performance - Phreesia's shares have returned +12.3% over the past month, outperforming the Zacks S&P 500 composite's +3.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]
OSI (OSIS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-08-21 15:01
Group 1 - OSI Systems reported revenue of $504.99 million for the quarter ended June 2025, reflecting a 5% increase year-over-year and a surprise of +2.34% over the Zacks Consensus Estimate of $493.43 million [1] - The earnings per share (EPS) for the quarter was $3.24, compared to $2.84 in the same quarter last year, resulting in an EPS surprise of +1.57% against the consensus estimate of $3.19 [1] - The stock has returned -1.4% over the past month, while the Zacks S&P 500 composite has changed by +1.7%, with a Zacks Rank 2 (Buy) indicating potential outperformance in the near term [3] Group 2 - Revenue from the Healthcare division was $42.68 million, which is -15.2% lower than the estimated $50.9 million [4] - Intersegment eliminations reported revenue of $-17.34 million, showing a +24.1% change compared to the year-ago quarter [4] - The Optoelectronics and Manufacturing division generated $112.67 million in revenue, exceeding the average estimate of $107.37 million, representing a +10.4% year-over-year change [4] - The Security division reported revenue of $366.97 million, surpassing the average estimate of $349.95 million, with a +7.1% change year-over-year [4] - Non-GAAP operating income for the Security Division was $74.71 million, above the average estimate of $71.57 million [4] - Non-GAAP operating income for the Healthcare Division was $0.37 million, below the average estimate of $4.31 million [4] - Non-GAAP operating income for the Optoelectronics and Manufacturing Division was $15.33 million, slightly above the average estimate of $15.32 million [4]
Superior HealthPlan and Centene Foundation Announce Grand Opening of CHDI Multi-Purpose Community Health Center in Uvalde
Prnewswire· 2025-07-28 15:45
Core Insights - A new $16 million multi-purpose community health center has been opened in Uvalde, Texas, managed by Community Health Development, Inc. (CHDI), providing healthcare services, community support, and resources for the local community [1][2]. Group 1: Project Background - The health center was announced following the Robb Elementary School shooting in May 2022, addressing the urgent need for comprehensive physical, behavioral, and emotional health services [3]. - CHDI identified three key initiatives in response to the community's needs: building the new health center, establishing a school-based health center, and creating the Robb Elementary School Dream Scholarship Fund [3]. Group 2: Funding and Community Impact - The center received over $8 million in funding from the Centene Foundation and Superior HealthPlan, which serves one in four individuals in the county [4]. - CHDI serves more than 12,000 people annually in the region, and the new center is expected to fill critical gaps in the healthcare system, making a lasting impact on the health of Uvalde [5][8]. Group 3: Facility Features - The 16,000-square-foot facility includes seven primary medical care examination rooms, three dental operatories, behavioral health services via telehealth, a Class A pharmacy, a medical laboratory, and a community room with a capacity for over 150 people [7]. - Additional features include a tranquility garden honoring the victims of the Robb Elementary School tragedy, office space for Texas Rio Grande Legal Aid, and a college/job preparation training space for students [7]. Group 4: Organizational Background - CHDI, founded in 1983, aims to increase access to primary healthcare and is recognized as a Patient Centered Medical Home, receiving Gold Tier recognition as a Health Center Quality Leader [8]. - Superior HealthPlan, a managed care company under Centene, has been providing healthcare services to Texans for over 25 years, supporting local involvement across all Texas counties [9]. Group 5: Philanthropic Efforts - The Centene Foundation focuses on investing in economically challenged communities, addressing social drivers of health, and improving health equity through healthcare access, social services, and education [10].
munity Health Systems(CYH) - 2025 Q2 - Earnings Call Transcript
2025-07-24 16:00
Financial Data and Key Metrics Changes - In the second quarter, same store net revenue increased by 6.5% year over year, primarily driven by rate growth and recognition of revenue under Medicaid state directed payment programs in New Mexico and Tennessee [9][15][16] - Adjusted EBITDA for the second quarter was $380 million compared to $387 million in the prior year, with a margin of 12.1% versus 12.3% in the prior year [16][17] - Cash flows from operations were reported at $87 million for the second quarter and $282 million year to date, with free cash flows for the second quarter being marginally positive [17][18] Business Line Data and Key Metrics Changes - Inpatient admissions increased by 0.3% year over year, while adjusted admissions declined by 0.7%, with same store surgeries down by 2.5% and emergency department visits down by 1.9% [9][15][16] - The company has over 200 providers scheduled to commence in the second half of 2025, indicating a focus on expanding service lines and capacity [10][11] Market Data and Key Metrics Changes - The company noted a decline in consumer confidence, which has affected demand for healthcare services, particularly elective surgical procedures [13][25] - The company is experiencing a softer demand for elective surgeries, particularly in the commercial book, which has led to a loss of operating leverage [13][14] Company Strategy and Development Direction - The company is focused on expanding its physical capacity and service lines, with ongoing recruitment of primary care and specialty physicians [10][11] - Recent service line and capacity expansions in key markets are expected to ramp up and gain market share, with new outpatient access points set to open [11] - The company completed the divestiture of Cedar Park Regional Medical Center for $436 million and is working on improving its leverage profile through successful debt refinancing [11][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence that past development and capital investment strategies have positioned the company well to capture patient demand once consumer confidence returns [9][10] - The company anticipates that the impacts from the recently signed budget reconciliation for the One Big Beautiful Bill Act will phase in beginning in 2027, projecting a cumulative reduction in EBITDA of approximately $300 to $350 million over the next thirteen years [19][20] - Management is taking a conservative approach to the underlying business given the impact from macro factors observed in the second quarter [22] Other Important Information - The CEO announced plans to retire in September, with the President and CFO expected to take over leadership [5][8] - The company is actively pursuing legislative and administrative fixes to mitigate the impacts of the One Big Beautiful Bill Act [20][21] Q&A Session Summary Question: Volume expectations and dynamics - Management noted a decline in consumer confidence affecting volumes, with a revised guidance for adjusted admissions for the year now expected to be 0% to 1% [25][26] Question: Updates on state directed payment programs - Management provided updates on pending DPP programs in Indiana and Florida, expecting material benefits from these programs once approved [30][31] Question: Run rate for EBITDA going forward - Management indicated that the real run rate for EBITDA is likely in the range of $360 million to $375 million, considering the current volume trends [36] Question: Impact of the One Big Beautiful Bill Act - Management explained the complexities of estimating the impact of the bill, emphasizing ongoing lobbying efforts to address potential funding cuts [19][20][92] Question: Medicare volume trends - Management reported no significant changes in the Medicare book of business, indicating that this segment is less impacted by consumer confidence issues [76] Question: Differences in volume trends compared to peers - Management suggested that geographic differences and types of markets may contribute to the volume discrepancies observed compared to peers [80][81]
巴西接触研究所:作为公共政策的修订版
OECD· 2025-06-09 04:10
Investment Rating - The report does not explicitly provide an investment rating for the health accounts in Brazil. Core Insights - The institutionalization of health accounts in Brazil is essential for systematic monitoring of health expenditures, which is crucial for informed health policy decisions. The OECD supports this initiative to align with international standards and enhance the analytical potential of health accounts [15][16][27]. Summary by Sections Introduction - The report emphasizes the importance of systematic monitoring of health expenditures due to increasing demand for healthcare services and the need for efficient allocation of public funds. The OECD is assisting Brazil in implementing and institutionalizing health accounts as a tool for tracking health spending [39][40]. National Health Accounts as a Monitoring Tool - National health accounts are vital for systematically tracking health expenditures and informing public policy decisions. The chapter discusses the historical context of health accounts in OECD countries and Brazil, highlighting previous attempts to institutionalize health accounts in Brazil [53][54]. Overview of the Brazilian Health System - The introduction of the Unified Health System (SUS) has increased access to health services for a large portion of the population. However, the financing of SUS is complex, and private health insurance plays a significant role in Brazil [23][25]. New Approach to Institutionalizing Health Accounts in Brazil - The Brazilian Ministry of Health has committed to annual health accounts to fully utilize this analytical tool. The report provides recommendations for institutionalizing regular health accounts and disseminating results for greater political impact [16][27][36]. Contextualizing Brazil's Health Expenditure Data Internationally - Brazil's health expenditure per capita is lower than most OECD countries, with 45% of total health spending coming from compulsory financing regimes, significantly lower than the OECD average of 75%. The role of voluntary health insurance is more pronounced in Brazil, accounting for 27% of total health spending [32][31]. Expanding the Scope of Health Accounts in Brazil - The report suggests mapping health expenditures to providers, completing the financing landscape, and monitoring investments in the health sector for future resilience. It also highlights regional variations in health spending and the need for detailed expenditure data by disease and demographics [20][6]. Strengthening Health Accounts in Brazil - Institutionalization requires a solid foundation, governance, and political impact. The report emphasizes the importance of establishing a dedicated team for national health accounts and maintaining good relationships with data providers [7][34][35].